Reactive perforating collagenosis associated with scabies in a diabetic

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 5, 2004, Pages 588-590

  Brinkmeier, T ^a   Herbst, R A ^a   Frosch, P J ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Acquired reactive perforating collegenosis; Diabetis mellitus; Pruritus; Scabies; Tetracyclines

Indexed keywords

ALLOPURINOL; CORTICOSTEROID DERIVATIVE; DIMETINDENE; DOXYCYCLINE; GLIBENCLAMIDE; HEXACHLOROCYCLOHEXANE; IVERMECTIN; LEVOCETIRIZINE; PERMETHRIN; POLIDOCANOL; PREDNICARBATE; RETINOIC ACID DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; COLLAGEN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG TOLERABILITY; EPILUMINESCENCE MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; PUVA; SCABIES; SKIN BIOPSY; SKIN NODULE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

COLLAGEN DISEASES; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOWER EXTREMITY; MIDDLE AGED; PRURITUS; SCABIES;

EID: 4544294980     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00978.x     Document Type: Article

References (14)

1. Mehregan AH, Schwartz OD, Livingood CS. Reactive perforating collagenosis. Arch Dermatol 1967; 96: 277-282.
2. Poliak SC, Lebwohl MG, Parris A, Prioleau PG. Reactive perforating collagenosis associated with diabetes mellitus. N Engl J Med 1982; 306: 81-84.
3. Morton CA, Henderson IS, Jones MC, Lowe JG. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 1996; 135: 671-677.
4. Faver IR, Daoud MS, Su WP. Acquired reactive perforating collagenosis. J Am Acad Dermatol 1994; 30: 575-580.
5. Satchell AC, Crotty K, Lee S. Reactive perforating collagenosis: a condition that may be underdiagnosed. Australas J Dermatol 2001; 42: 284-287.
6. Theile-Oche S, Schneider LA, Reinhold K et al. Acquired perforating collagenosis: is it due to damage by scratching? Br J Dermatol 2001; 145: 173-174.
7. Kurschat P, Kroger A, Scharffetter-Kochanek K, Hunzelmann N. Acquired reactive perforating collagenosis triggered by scabies infection. Acta Derm Venereol 2000; 80: 384-385.
8. Farrell AM. Acquired perforating dermatosis in renal and diabetic patients. Lancet 1997; 349: 895-896.
9. Chang C, Houck JC. Demonstration of the chemotactic properties of collagen. Proc Soc Exp Biol Med 1970; 134: 22-26.
10. Yanagihara M, Fujita T, Shirasaki A et al. The pathogenesis of the transepithelial elimination of the collagen bundles in acquired reactive perforating collagenosis. J Cutan Pathol 1996; 23: 398-403.
11. Zelger B, Hintner H, Auböck J, Fritsch PO. Acquired perforating dermatosis. Transepidermal elimination of DNA material and possible role of leukocytes in pathogenesis. Arch Dermatol 1991; 127: 695-700.
12. Brinkmeier T, Schaller J, Herbst RA, Frosch PJ. Successful treatment of acquired reactive perforating collagenosis with doxycycline. Acta Derm Venereol 2002; 82: 393-395.
13. Gabler WL, Smith J, Tsukuda N. Comparison of doxycycline and a chemically modified tetracycline inhibition of leukocyte functions. Res Commun Chem Pathol Pharmacol 1992; 78: 151-160.
14. Ryan ME, Usman A, Ramamurthy NS et al. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 2001; 8: 305-316.